# S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC)

> **NCT06026865** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Medical University of Warsaw** · enrollment: 60 (actual)

## Conditions studied

- Primary Sclerosing Cholangitis (PSC)

## Interventions

- **DIETARY_SUPPLEMENT:** S-Adenosyl-L-methionine (SAMe)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06026865
- **Lead sponsor:** Medical University of Warsaw
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-08-01
- **Primary completion:** 2025-07-31
- **Final completion:** 2026-06-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06026865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06026865, "S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06026865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*